纳米羟基磷灰石负载埃博霉素B的细胞活性研究

羟基磷灰石(HA)纳米材料因其生物相容性好,比表面积大,可以吸附大量的药物分子,因此在纳米医药领域极具应用前景。本文通过共沉淀法制备出纳米HA(HA NPs),然后利用XRD,FT IR,SEM,TEM进行表征,结果表明,所制备的HA NPs呈针形,长约70~90nm。实验表明,采用二氯甲烷作为溶剂,埃博霉素B(Epo B)负载效率最高,最大负载量达0.53g/(g HA)。应用MTT法对HA NPs及复合物的抗肿瘤活性进行分析,结果显示HA-Epo B复合物对肺癌细胞NCI-H292和LLC的IC50浓度分别为15和35 ng/m L,明显低于游离Epo B的IC5035和50 ng/m L。这可能是HA NPs更容易进入细胞内,然后将药物释放,进而抑制肿瘤细胞生长。     

微流控可控分步组装制备透明质酸/聚乙烯亚胺/DNA纳米复合物

阳离子聚合物/DNA形成的复合物纳米颗粒呈正电性,因此表面必须遮盖一层电中性或负电性的聚合物才能在体内应用,但如何控制遮蔽层在复合物纳米颗粒上组装,形成结构可控、尺寸均一的基因输送系统是关键.本文以基因输送系统中常见的透明质酸(HA)/聚乙烯亚胺(PEI)/DNA系统为例,探索了利用微流控芯片进行可控分步的层层自组装,制备尺寸大小均一、表面电势为负的HA/PEI/DNA纳米复合物的方法.将PEI与DNA通过第一个微流控芯片自组装得到PEI/DNA纳米复合物,该复合物颗粒在第二个微流控芯片内与HA再次组装得到HA/PEI/DNA纳米复合物.考察了微流控芯片管道的尺寸、溶液流速及流速比R、PEI与DNA氮磷比(N:P)、HA与DNA质量比(HA:DNA)等参数与所形成的纳米复合物的尺寸、均一性及表面电势的关系,并与涡旋振荡法制备的复合物进行比较.结果表明,传统的涡旋振荡法制备的HA/PEI/DNA纳米复合物尺寸偏大(340～490 nm)、均一度低(PDI,0.506～0.863);而用微流控法制备的复合物尺寸较小(190 nm)、分布更为均一(PDI=0.316).     

聚多巴胺仿生纳米微球用于构建电化学免疫传感器

利用多巴胺仿生聚合方法制备了具有良好生物相容性的聚多巴胺纳米微球,并在其表面原位合成银纳米颗粒.复合物微球具有良好的催化还原H2O2的性能以及良好的结合生物分子的能力.将制备的复合物微球作为标记物,将氨基化石墨烯作为基底材料,构建了检测人免疫球蛋白(Ig G)的夹心型电化学免疫传感器.运用循环伏安法和计时电流法对构建的电化学免疫传感器进行了性能分析,并对实验条件进行了考察优化.在最佳的实验条件下,免疫传感器的线性范围是0.1 pg/m L~15 ng/m L,检出限为0.025 pg/m L.     

碲化镉纳米晶标记抗荧蒽抗体及其荧光免疫分析

以水热法合成的碲化镉(CdTe)纳米晶标记抗荧蒽抗体后,标记复合物的荧光强度增强,其分散性和稳定性良好。将此标记物用于直接竞争荧光免疫分析,测定了环境水样中荧蒽的含量。结果表明,在0.1～1000μg/L范围内有良好的线性关系;抑制率IC50为12.4μg/L,检出限IC20为13.1ng/L。对水样进行加标回收实验,回收率在95.1%～111%之间;相对标准偏差小于9%。本方法准确可靠,结果满意,能够满足环境中微量环境激素类污染物的检测需要。     

基于Fe_3O_4磁性纳米粒子的QuEChERS预处理方法联合GC-MS对血液中多种苯二氮卓类药物检测

基于Fe_3O_4磁性纳米粒子(MNPs)的QuEChERS预处理方法联合气相色谱串联质谱(GC-MS),建立了检测血液中多种苯二氮卓类药物的分析方法。利用QuEChERS提取法对血液样本进行预处理,处理过程中加入Fe_3O_4M NPs作为新型杂质吸附剂,采用外部磁铁进行两相分离,GC-MS法对多种苯二氮卓类药物进行快速定量检测。在最佳检测条件下,5种药物质量浓度在0.5~5.0μg/m L的范围内线性良好,r0.9872,检出限在0.103~0.412μg/m L之间。日内和日间相对标准偏差(RSD)均8.7%,方法的回收率在88.2%~113.2%之间。方法的分析性能能够满足临床对血液中药物检测的要求,在药物分析方面具有应用前景。     

MWCNTs-rGO/PDDA-AuNPs复合膜修饰电极对莱克多巴胺的灵敏检测

采用自组装方法,将聚二烯丙基二甲基氯化铵(PDDA)功能化的金纳米颗粒(Au NPs)负载于多壁碳纳米管(MWCNTs)-还原型氧化石墨烯(r GO)夹层,再涂覆于玻碳电极(GCE)上,制备了纳米复合膜修饰电极MWCNTs-r GO/PDDA-Au NPs/GCE.采用透射电子显微镜(TEM)和紫外-可见光谱(UV-Vis)对修饰膜的形貌及结构进行表征.探讨了其对莱克多巴胺(Rac)的循环伏安行为,结果表明MWCNTs-r GO/PDDA-Au NPs纳米复合物对Rac表现出显著的电催化氧化特性.采用差分脉冲伏安法测得该复合膜修饰电极对Rac检测的线性范围为0.036~4.5μmol/L,检出限为6.35 nmol/L(S/N≥3),且显示出良好的抗干扰能力、稳定性及重现性.采用该方法检测猪血清及猪尿样中的Rac,回收率达95.4%~105.9%,表明该复合膜修饰电极对实际样品中Rac的检测具有潜在应用价值.     

Fe_3O_4纳米粒子与慢病毒载体共同感染内皮祖细胞的促血管新生和MRI示踪的应用

采用化学共沉淀法制备了柠檬酸钠修饰Fe_3O_4纳米粒子(NPs),使用胎牛血清(FBS)改善Fe_3O_4NPs的分散性.实验表明Fe_3O_4NPs尺寸均匀,且具有良好的稳定性,FBS浓度小于5%(体积分数)时,Fe_3O_4NPs无聚集沉淀;在300 K下,饱和磁化强度达到74.86×10~(-3)A·m~2/g(74.86 emu/g);核磁共振T2序列成像时,75μg/m L Fe_3O_4NPs与慢病毒载体(LV)共同标记内皮祖细胞(EPCs)成像效果良好;而且EPCs具有稳定过表达目的基因血管内皮生长因子(VEGF)的能力.利用Fe_3O_4NPs与LV共同感染EPCs,可有效促进大鼠血管生成.说明修饰后的EPCs兼具核磁共振成像(MRI)示踪和促血管生成双重功能.     

基于Au纳米颗粒/还原氧化石墨烯C-反应蛋白免疫传感器的研制

采用还原氧化石墨烯-金纳米颗粒(RGO-Au NPs)作为免疫传感器的固定基质,将C-反应蛋白(CRP)抗体固定在玻碳电极表面,用蒽醌二羧酸作为标记物,制成夹心型的CRP免疫传感器。在最优实验条件下,通过示差脉冲伏安法对CRP的含量进行检测。该传感器在0.25~100 ng/m L范围内具有良好的线性关系,检出限为0.08 ng/m L,线性系数为0.997。该传感器为C-反应蛋白的检测提供了一种新的手段。     

基于纳米金-罗丹明B体系检测甲巯咪唑的研究

基于不同聚集态金纳米粒子(Au NPs)对罗丹明B(Rh B)的荧光猝灭作用,建立了一种简单、灵敏、快速测定药物甲巯咪唑的新方法。初步探讨了方法机理,并对p H值、反应时间、Au NPs和Rh B的浓度等实验条件进行了优化。优化实验条件下,方法的线性范围为4.38×10-8~0.876×10-5mol/L,检出限(S/N=3)为3.30×10-8mol/L。该法用于甲巯咪唑药品中甲巯咪唑的测定,获得了满意结果。     

纳米固相微萃取应用于干红辣椒、水果饮料及红酒中罗丹明B的定量分析（英文）

制备了一种新型的聚苯乙烯纳米纤维,将其作为固相萃取吸附剂装填制成固相萃取柱,与高效液相色谱联用建立了干辣椒、水果饮料及红酒中罗丹明B的定量分析方法.高效液相色谱以3 g/L磷酸缓冲液-甲醇混合溶液(体积比3∶7,pH=7.0)为流动相.通过对提取条件的优化,得到该方法对干辣椒中罗丹明B的检出限为0.1 ng/g,最低定量限为0.6 ng/g;对水果饮料和红酒中罗丹明B的检出限均为0.2 ng/m L,最低定量限均为0.5 ng/m L.此方法对干辣椒中罗丹明B的提取回收率为98.2%~110.3%;对水果饮料中罗丹明B的提取回收率为94.6%~102.2%;对红酒中罗丹明B的提取回收率为90.4%~104.6%.该方法的线性范围为1~100 ng/m L(ng/g),相对标准偏差为2.3%~9.0%.该方法灵敏度高、选择性好,可用于干辣椒、水果饮料及红酒中罗丹明B的定量分析.     

Antiproliferative activity, antioxidant capacity and tannin content in plants of semi-arid northeastern Brazil

The objective of this study was to evaluate antiproliferative activity, antioxidant capacity and tannin content in plants from semi-arid northeastern Brazil (Caatinga). For this study, we selected 14 species and we assayed the methanol extracts for antiproliferative activity against the HEp-2 (laryngeal cancer) and NCI-H292 (lung cancer) cell lines using the (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazole) (MTT) method. In addition, the antioxidant activity was evaluated with the DPPH (2,2-diphenyl-2-picrylhydrazyl) assay, and the tannin content was determined by the radial diffusion method. Plants with better antioxidant activity (expressed in a dose able to decrease the initial DPPH concentration by 50%, or IC50) and with higher levels of tannins were: Poincianella pyramidalis (42.95±1.77 μg/mL IC50 and 8.17±0.64 tannin content), Jatropha mollissima (54.09±4.36μg/mL IC50 and 2.35±0.08 tannin content) and Anadenanthera colubrina (73.24±1.47 μg/mL IC50 and 4.41±0.47 tannin content). Plants with enhanced antiproliferative activity (% living cells) were Annona muricata (24.94±0.74 in NCI-H292), Lantana camara (25.8±0.19 in NCI-H292), Handroanthus impetiginosus (41.8±0.47 in NCI-H292) and Mentzelia aspera (45.61±1.94 in HEp-2). For species with better antioxidant and antiproliferative activities, we suggest future in vitro and in vivo comparative studies with other pharmacological models, and to start a process of purification and identification of the possible molecule(s) responsible for the observed pharmacological activity. We believe that the flora of Brazilian semi-arid areas can be a valuable source of plants rich in tannins, cytotoxic compounds and antioxidant agents.     

Citrus sinensis leaf aqueous extract green-synthesized silver nanoparticles: Characterization and cytotoxicity,antioxidant, and anti-human lung carcinoma effects

The present work demonstrates the synthesis of Ag nanoparticles (Ag NPs) by using aqueous extract of Citrus sinensis as green reductant and capping agent without any toxic reagent. Physicochemical characteristics of the said nanoparticles were elucidated by field emission scanning electron microscopy (FESEM), fourier transform infrared spectroscopy (FTIR), and ultraviolet–visible spectroscopy (UV-Vids) techniques. The biogenic Ag NPs are uniformly globular. The Ag NPs has been explored biologically in the anticancer and antioxidant assays. In the cellular and molecular part of the recent study, the treated cells with Ag NPs were assessed by MTT assay for 48 h about the cytotoxicity and anti-human lung carcinoma properties on normal (HUVEC) and lung carcinoma cell lines i.e. NCI-H661, HLC-1, NCI-H1563, LC-2/ad, NCI-H1299, and PC-14. The viability of malignant lung cell line reduced dose-dependently in the presence of Ag NPs. The IC50 of Ag NPs were 82, 139, 170, 66, 62, and 50 µg/mL against NCI-H661, HLC-1, NCI-H1563, LC-2/ad, NCI-H1299, and PC-14 cell lines, respectively. In the antioxidant test, the IC50 of Ag NPs and vitamin E against 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radicals were 21 and 15 µg/mL, respectively. After clinical study, Ag NPs containing Citrus sinensis leaf aqueous extract may be used to formulate a new chemotherapeutic drug or supplement to treat the several types of human lung adenocarcinoma.     

Biologically active constituents of Aglaia erythrosperma

From the fruits and leaves of Aglaia erythrosperma (Meliaceae), 10 chemical constituents were isolated and identified, i.e. the dammarane triterpenoids cabraleadiol (1), cabraleahydroxylactone (2), ethyl eichlerianoate (3), eichlerialactone (4), aglinin A (5), cabralealactone (6), the aglaialactone 5,6-desmethylenedioxy-5-methoxy-aglalactone (7), the flavagline 4'-demethoxy-3',4'-methylenedioxy-methyl rocaglate (8) and two coumarins: scoparone and scopoletin. Flavagline 8 exhibited antimalarial activity with an IC(50) value of 7.30 μg mL(-1) and was strongly cytotoxic against small cell lung cancer (NCI-H187), epidermoid carcinoma (KB) and breast cancer (BC) cell lines, with IC(50) values of 2.17, 2.10 and 0.11 μg mL(-1), respectively. Aglinin A (5) displayed moderate cytotoxicity against all the three cancer cell lines, whereas ethyl eichlerianoate (3), cabralealactone (6) and the aglaialactone 7 were exclusively cytotoxic to NCI-H187 cell line. Cabraleahydroxylactone (2) showed antiviral activity against herpes simplex virus type-1 with an IC(50) value of 3.20 μg mL(-1), in comparison with the standard acyclovir (IC(50)?= 1.90 μg mL(-1)). When tested for antimycobacterial activity against Mycobacterium tuberculosis H(37)Ra, compounds 1-4 and 6-8 displayed minimum inhibitory concentration in the range of 25-50 μg mL(-1).     

Cytotoxic prenylated xanthones from the young fruit of Garcinia mangostana

Three new prenylated xanthones, mangostenones C (1), D (2), and E (3), together with 16 known xanthones 4-19, were isolated from the young fruit (7-week maturity stage) of Garcinia mangostana. The structural elucidation of the new compounds was mainly established on the basis of 1D and 2D NMR and HR-MS spectroscopic analysis. Compound 1 showed cytotoxic properties against three human cancer cell lines, epidermoid carcinoma of the mouth (KB), breast cancer (BC-1), and small cell lung cancer (NCI-H187), with IC50 values of 2.8, 3.53, and 3.72 microg/ml, respectively. Among the isolates, alpha-mangostin (12), the major metabolite, exhibited the most potent effects against the BC-1 cells with an IC50 value of 0.92 microg/ml, an activity greater than that of the standard drug ellipticine (IC50 = 1.46 microg/ml). Compound 12 also showed the highest activity against KB cells, while gartanin (10) displayed the strongest activity against the NCI-H187 cells at the respective IC50 values of 2.08 microg/ml and 1.08 microg/ml.     

FePt@CoS(2) yolk-shell nanocrystals as a potent agent to kill HeLa cells

We report the evaluation of cytotoxicity of a new type of engineered nanomaterials, FePt@CoS(2) yolk-shell nanocrystals, synthesized by the mechanism of the Kirkendall effect when FePt nanoparticles serve as the seeds. The cytotoxicity of FePt@CoS(2) yolk-shell nanocrystals, evaluated by MTT assay, shows a much lower IC(50) (35.5 +/- 4.7 ng of Pt/mL for HeLa cell) than that of cisplatin (230 ng of Pt/mL). In the control experiment, cysteine-modified FePt nanoparticles exhibit IC50 at 12.0 +/- 0.9 microg of Pt/mL. Transmission electron microscopy confirms the cellular uptake of FePt@CoS(2) nanocrystals, and the magnetic properties analysis (SQUID) proves the release of FePt nanoparticles from the yolk-shell nanostructures after cellular uptake. These results are significant because almost none of the platinum-based complexes produced for clinical trials in the past 3 decades have shown higher activity than that of the parent drug, cisplatin. The exceptionally high toxicity of FePt@CoS(2) yolk-shell nanocrystals (about 7 times higher than that of cisplatin in terms of Pt) may lead to a new design of an anticancer nanomedicine.     

Supported silver nanoparticles over alginate-modified magnetic nanoparticles: Synthesis,characterization and treat the human lung carcinoma

This article displays synthesis of Silver nanoparticles (Ag NPs) decorated on sodium alginate covered magnetite (Fe₃O₄/Alg-Ag NPs) nanocomposite. Sodium alginate shell as a natural anionic polysaccharide on Fe₃O₄ microparticles core acted as a stabilizing agent for the reduction of Ag(I) ions into Ag NPs. The structural features of the synthesized nanocomposite were investigated by fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), field emission scanning electron microscopes (FE-SEM), transmission electron microscopes (TEM), energy-dispersive X-ray spectroscopy (EDX) and vibrating-sample magnetometer (VSM) studies and inductively coupled plasma-optical emission spectroscopy (ICP-OES). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay was used on common lung cancer cell lines i.e., NCI-H1975, NCI-H1563, and NCI-H1299 to survey the cytotoxicity and anti-lung cancer effects of the synthesized nanocomposite. The synthesized nanocomposite had very low cell viability and high anti-lung cancer activities dose-dependently against NCI-H1975, NCI-H1563, and NCI-H1299 cell lines without any cytotoxicity on the normal cell line (Human umbilical vein endothelial cells (HUVECs)). To determine the antioxidant properties of the synthesized nanocomposite, the 2,2-diphenyl-1-picrylhydrazyl (DPPH) test was used in the presence of butylated hydroxytoluene as the positive control. The synthesized nanocomposite inhibited half of the DPPH molecules in the concentration of 194 µg/mL. Maybe significant anti-human lung cancer potentials of the synthesized nanocomposite against common human lung cancer cell lines are linked to their antioxidant activities.     

Biogenic Synthesis of NiO Nanoparticles Using Areca catechu Leaf Extract and Their Antidiabetic and Cytotoxic Effects

Nanoworld is an attractive sphere with the potential to explore novel nanomaterials with valuable applications in medicinal science. Herein, we report an efficient and ecofriendly approach for the synthesis of Nickel oxide nanoparticles (NiO NPs) via a solution combustion method using Areca catechu leaf extract. As-prepared NiO NPs were characterized using various analytical tools such as powder X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), and UV-Visible spectroscopy (UV-Vis). XRD analysis illustrates that synthesized NiO NPs are hexagonal structured crystallites with an average size of 5.46 nm and a hexagonal-shaped morphology with slight agglomeration. The morphology, size, and shape of the obtained material was further confirmed using SEM and TEM analysis. In addition, as-prepared NiO NPs have shown potential antidiabetic and anticancer properties. Our results suggest that the inhibition of α-amylase enzyme with IC 50 value 268.13 µg/mL may be one of the feasible ways through which the NiO NPs exert their hypoglycemic effect. Furthermore, cytotoxic activity performed using NiO NPs exhibited against human lung cancer cell line (A549) proved that the prepared NiO NPs have significant anticancer activity with 93.349 μg/mL at 50% inhibition concentration. The biological assay results revealed that NiO NPs exhibited significant cytotoxicity against human lung cancer cell line (A549) in a dose-dependent manner from 0–100 μg/mL, showing considerable cell viability. Further, the systematic approach deliberates the NiO NPs as a function of phenolic extracts of A. catechu with vast potential for many biological and biomedical applications.     

基于BHHCT-Eu3+@SiO2荧光稀土二氧化硅纳米颗粒的免疫层析试纸条检测卡那霉素

采用微波辅助合成的荧光稀土二氧化硅纳米颗粒(BHHCT-Eu3+@SiO2)为标记物,建立了快速定量检测卡那霉素(Kana)残留的荧光免疫层析方法.实验结果表明,微波辅助合成的BHHCT-Eu3+@SiO2纳米颗粒呈球形,粒径约36 nm,具有良好的荧光发射性能,最大吸收波长和最大发射波长分别为343和615 nm.将BHHCT-Eu3+@SiO2与卡那霉素抗体(Kana-ab)通过醛基化葡聚糖交联,合成了荧光标记抗体Eu3+-Kana-ab,结合定量侧向层析读数仪,建立了牛奶中Kana残留的快速定量检测方法,对Kana的检出限(IC10)为0.85 ng/mL,半数抑制浓度(IC50)为12.76 ng/mL,检测范围(IC20-IC80)为3.0~76.0 ng/mL,牛奶中的Kana的加标回收率范围为93.7%~97.4%,RSD为3.1%~4.6%,与Kana类似物的交叉反应均<1%.牛奶中Kana残留的测定结果与ELISA方法相关性良好.     

Facile preparation of Kaolin supported silver nanoparticles mediated by Thymbra spicata extract and investigation of the anti-human lung cancer properties

The present work demonstrates the synthesis of kaolin supported Ag nanoparticles (AgNPs@Kaolin) by using an aqueous extract of Thymbra spicata as a green reductant and capping agent. Physicochemical characteristics of the synthesized nanocomposite were studied by field emission scanning electron microscopy (FESEM), transmission electron microscopy (TEM), energy-dispersive X-ray spectroscopy (EDS), elemental mapping, X-ray diffraction (XRD) and inductively coupled plasma (ICP) techniques. The biogenic AgNPs are uniformly globular. Owing to the surface modification by the plant derived phytochemicals, the NPs are found to be distributed evenly on the kaolin surface. The AgNPs@Kaolin nanocomposite has been explored biologically in the anticancer and antioxidant assays. In the cellular and molecular part of the recent study, the treated cells with AgNPs@Kaolin nanocomposite were assessed by MTT assay for 48 h about the cytotoxicity and anti-human lung adenocarcinoma properties on normal (HUVEC) and lung adenocarcinoma cell lines i.e. lung well-differentiated bronchogenic adenocarcinoma (HLC-1), lung moderately differentiated adenocarcinoma (LC-2/ad), and lung poorly differentiated adenocarcinoma (PC-14). The viability of malignant lung cell line reduced dose-dependently in the presence of AgNPs@Kaolin nanocomposite. The IC50 of AgNPs@Kaolin nanocomposite were 509, 315, and 189 µg/mL against HLC-1, LC-2/ad, and PC-14 cell lines, respectively. In the antioxidant test, the IC50 of AgNPs@Kaolin nanocomposite and BHT against DPPH free radicals were 125 and 161 µg/mL, respectively. After the clinical study, AgNPs@Kaolin nanocomposite containing T. spicata leaf aqueous extract may be used to formulate a new chemotherapeutic drug or supplement to treat the several types of human lung adenocarcinoma.     

Doxorubicin-Conjugated Zinc Oxide Nanoparticles,Biogenically Synthesised Using a Fungus Aspergillus niger,Exhibit High Therapeutic Efficacy against Lung Cancer Cells

This study reports the therapeutic effectiveness of doxorubicin-conjugated zinc oxide nanoparticles against lung cancer cell line. The zinc oxide nanoparticles (ZnONPs) were first synthesised using a fungus, isolated from air with an extraordinary capability to survive in very high concentrations of zinc salt. Molecular analysis based on 18S rRNA gene sequencing led to its identification as Aspergillus niger with the NCBI accession no. {"type":"entrez-nucleotide","attrs":{"text":"OL636020","term_id":"2155690654"}}OL636020. The fungus was found to produce ZnONPs via the reduction of zinc ions from zinc sulphate. The ZnONPs were characterised by various biophysical techniques. ZnONPs were further bioconjugated with the anti-cancer drug doxorubicin (DOX), which was further confirmed by different physical techniques. Furthermore, we examined the cytotoxic efficacy of Doxorubicin-bioconjugated-ZnONPs (DOX-ZnONPs) against lung cancer A549 cells in comparison to ZnONPs and DOX alone. The cytotoxicity caused due to ZnONPs, DOX and DOX-ZnONPs in lung cancer A549 cells was assessed by MTT assay. DOX-ZnONPs strongly inhibited the proliferation of A549 with IC50 value of 0.34 μg/mL, which is lower than IC50 of DOX alone (0.56 μg/mL). Moreover, DOX-ZnONPs treated cells also showed increased nuclear condensation, enhanced ROS generation in cytosol and reduced mitochondrial membrane potential. To investigate the induction of apoptosis, caspase-3 activity was measured in all the treated groups. Conclusively, results of our study have established that DOX-ZnONPs have strong therapeutic efficacy to inhibit the growth of lung cancer cells in comparison to DOX alone. Our study also offers substantial evidence for the biogenically synthesised zinc oxide nanoparticle as a promising candidate for a drug delivery system.